Aaron Sato, Chief Strategy Officer, will present Adimab's journey from startup to leading antibody platform.

William Roach hosts a table discussion on challenges and solutions in bi- and multispecific antibodies.

Brad Lunde and Aaron Sato moderate panel discussions for multispecifics and peptides.

Garrett Rappazzo will present "Specificity of rare high-affinity human TCRs derived from synthetic yeast-based libraries."

Aaron Sato presents engineering advances in CD3 binding and T cell engager design and development.